# Organoid-Guided Chemotherapy for Advanced Pancreatic Cancer

> **NCT04931381** · PHASE3 · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Advanced Pancreatic Cancer

## Interventions

- **OTHER:** Chemotherapy guided by organoid drug sensitivity test

## Key facts

- **NCT ID:** NCT04931381
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2024-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04931381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04931381, "Organoid-Guided Chemotherapy for Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04931381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*